Contact this trialFirst, we need to learn more about you.
NMDA receptor antagonist
Emraclidine for Schizophrenia
Recruiting0 awardsPhase 2
Shreveport, Louisiana
This trial is testing a medication called Emraclidine in people with schizophrenia who are having a worsening of their symptoms. Emraclidine works by targeting brain chemicals to help reduce psychotic episodes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.